Endothelin Concentrations in a Population With Cardiovascular Disease and Periodonitis
Study Details
Study Description
Brief Summary
Recently, a key role played in the ethiology of periodontitis has been highlighted by a Endothelin (ET-1). ET1 possess the ability to express surface antigens of endothelial and hematopoietic stem cells and to assist in maintaining vascular integrity and the repair mechanism of the endothelium. ET originate from bone marrow
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The aim of the present study was to investigate the association between ET-1 in patients with periodontitis. Furthermore, the objective was to determine if the periodontal status influenced ET-1 levels.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Control Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease |
Other: Observation
Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease
|
Periodontitis Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease |
Other: Observation
Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease
|
Cardiovascular Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease |
Other: Observation
Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease
|
Periodontitis+Cardiovascular Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease |
Other: Observation
Evaluation of ET-1 level and correlation of ET-1 levels with periodontal and cardiovascular disease
|
Outcome Measures
Primary Outcome Measures
- Evaluation of ET-1 levels [1 year]
Correlation of ET-1 levels with periodontal and cardiovascular disease
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Presence of at least 16 teeth
-
CP with a minimum of 40% of sites with a clinical attachment level (CAL)
≥2mm and probing depth (PD) ≥4mm;
-
Presence of at least ≥2 mm of crestal alveolar bone loss verified on digital periapical radiographs
-
Presence of ≥40% sites with bleeding on probing (BOP)
Exclusion Criteria:
-
Intake of contraceptives
-
Intake of immunosuppressive or anti-inflammatory drugs throughout the last three months prior to the study
-
Status of pregnancy or lactation
-
Previous history of excessive drinking
-
Allergy to local anaesthetic
-
Intake of drugs that may potentially determine gingival hyperplasia such as Hydantoin, Nifedipine, Cyclosporin A or similar drugs.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Messina | Messina | Italy | 98125 |
Sponsors and Collaborators
- University of Messina
Investigators
- Study Director: Giovanni Matarese, University of Messina
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 10-918-10